PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Net margin 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) net profit margin by fiscal year — reported net income divided by reported revenue.
-1615.8%FY2025 · since FY2022: -359.4% → -1615.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1615.8% | -849.0 pp |
| FY2024 | -766.9% | -210.7 pp |
| FY2023 | -556.2% | -196.8 pp |
| FY2022 | -359.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice